Stevanato Group S.p.A. (STVN)
20.12
0.58 (2.97%)
At close: Feb 18, 2025, 3:59 PM
20.15
0.15%
After-hours: Feb 18, 2025, 07:00 PM EST
undefined% (undefined)
| Bid | 18 |
| Market Cap | 5.49B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.45 |
| PE Ratio (ttm) | 44.71 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 22.4 |
| Volume | 240,604 |
| Avg. Volume (20D) | 368,547 |
| Open | 19.50 |
| Previous Close | 19.54 |
| Day's Range | 19.31 - 20.38 |
| 52-Week Range | 16.56 - 34.00 |
| Beta | undefined |
About STVN
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, I...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Jul 16, 2021
Employees 5,635
Stock Exchange NYSE
Ticker Symbol STVN
Website https://www.stevanatogroup.com
Analyst Forecast
According to 6 analyst ratings, the average rating for STVN stock is "Buy." The 12-month stock price forecast is $26, which is an increase of 29.22% from the latest price.
Buy 66.67%
Hold 33.33%
Sell 0.00%
Next Earnings Release
Stevanato Group S.p.A. is scheduled to release its earnings on Mar 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+3.74%
Stevanto Group shares are trading higher after Wol...
Unlock content with
Pro Subscription
6 months ago
+5.75%
Stevanato Group shares are trading higher after the company reported better-than-expected Q2 revenue results.
